FIELD: pharmacology.
SUBSTANCE: compounds have a broad spectrum of antiviral activity and can be used for treatment and/or prevention of diseases caused by papillomavirus infection, infection caused by the immunodeficiency virus, cytomegalovirus or hepatitis B or C virus. In general formula I , X = CH2, Y = CH2CH2 or X = CH2CH2, Y = CH2; A is pyrimidine-4,6-diyl or pyrimidine-2,4-diyl, which may contain, as substituents, H, NO2, CHO, OH, OAlk, a halogen atom, NH(Alk), N(Alk) 2 group; wherein Alk is a linear or branched substituent having from 1 to 4 carbon atoms; Hal is a halogen atom, or X = Y = CH2; A is pyrimidin-4,6-diyl or pyrimidine-2,4-diyl, which has Cl, Br, CH3, HE atom as its substituent;Hal is a halogen, chlorine or bromine atom. Preference is given to compounds of formula (I) where X = CH2CH2, Y = CH2 or X = CH2, Y = CH2CH2, A = pyrimidine-4,6-diyl, which may have H, NO2, Alk group, as substituents; Hal = chlorine or bromine and Alk = methyl.
EFFECT: increased composition application effeciency.
11 cl, 2 dwg, 2 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
DERIVATIVES OF DI(DIAZONIADISPIRO[5.2.5.2]HEXADECANE)-5-NITROPYRIMIDINE AND THEIR USE FOR TREATMENT OF CORONAVIRUS INFECTIONS, IN PARTICULAR CAUSED BY SARS-COV-2 VIRUS | 2020 |
|
RU2761950C1 |
SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER | 2015 |
|
RU2607371C1 |
METHOD OF PRODUCING SUBSTITUTED PYRIMIDIN-5-YL CARBOXYLIC ACIDS | 2012 |
|
RU2485083C1 |
1,3-DIHYDROBENZIMIDAZOL-2-YLIDEN AMINES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2006 |
|
RU2410382C2 |
N-SUBSTITUTED DERIVATIVES OF OXAMIC ACID THIOHYDRAZIDES, SYNTHESIS METHOD AND USE THEREOF | 2009 |
|
RU2400471C1 |
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2091386C1 |
1-(2-AMINO-3-(SUBSTITUTED ALKYL)-3H-BENZIMIDAZOYLMETHYL)-3-SUBSTITUTED-1,3-DIHYDROBENZOIMIDAZOL-2-ONES HAVING RESPIRATORY SYNCYTIAL VIRUS ACTIVITY | 2006 |
|
RU2434000C2 |
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES | 1990 |
|
RU2068849C1 |
0 |
|
SU436494A3 |
Authors
Dates
2017-10-17—Published
2015-10-20—Filed